Mangoceuticals, Inc.
MGRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,707 | -$9,212 | -$1,998 | -$18 |
| Dep. & Amort. | $731 | $25 | $4 | $0 |
| Deferred Tax | $0 | $0 | -$152 | $0 |
| Stock-Based Comp. | $249 | $624 | $234 | $0 |
| Change in WC | $660 | $42 | $19 | $0 |
| Other Non-Cash | $2,203 | $1,524 | $547 | $0 |
| Operating Cash Flow | -$4,864 | -$6,997 | -$1,347 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$4 | -$43 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $65 | $0 | $0 | $0 |
| Investing Cash Flow | $65 | -$4 | -$43 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $150 | -$167 | $50 | $39 |
| Stock Issued | $1,328 | $6,200 | $2,000 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$802 | $0 | $0 | $0 |
| Other Fin. Act. | $3,452 | $1,025 | $0 | $0 |
| Financing Cash Flow | $4,128 | $7,057 | $2,050 | $40 |
| Forex Effect | -$10 | $0 | $0 | $0 |
| Net Chg. in Cash | -$680 | $56 | $660 | $23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $739 | $683 | $23 | $0 |
| End Cash | $59 | $739 | $683 | $23 |
| Free Cash Flow | -$4,864 | -$7,001 | -$1,390 | -$18 |